Advanced Heart Failure and Transplant Cardiology · Seattle, WA
NPI
1548423502
Since 2008
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1959 NE Pacific St
Seattle, WA, 98195
Phone (206) 598-4300
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
1,170 services
Medicare patients, 2024
546
Average age 72
Drug cost, 2024
$12.5M
3,153 prescriptions
Company payments, 2025
$263
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard K Cheng was code 93010 (electrocardiogram), 250 times for 210 patients. In total Richard K Cheng billed 1,170 services in 26 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 250 | 210 | $6.64 | $1,660 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 133 | 127 | $13.75 | $1,828 |
| 99233 Hospital E&M - Subsequent | Facility | 126 | 36 | $102.00 | $13K |
| 99214 Office E&M - Established | Facility | 107 | 103 | $74.88 | $8,012 |
| 93306 Echocardiography (TTE/TEE) | Office | 76 | 75 | $51.86 | $3,941 |
| 93356 Echocardiography (TTE/TEE) | Office | 67 | 64 | $9.22 | $618 |
| 99291 Critical Care E&M | Facility | 52 | 12 | $185.46 | $9,644 |
| 93010 Electrocardiogram | Office | 39 | 38 | $6.90 | $269 |
| 99215 Office E&M - Established | Facility | 39 | 36 | $118.17 | $4,609 |
| 93750 External Electrocardiographic Monitoring | Facility | 37 | 13 | $33.75 | $1,249 |
| 93505 Cardiovascular | Facility | 24 | 19 | $164.24 | $3,942 |
| 93451 Percutaneous Transcatheterization | Facility | 24 | 20 | $64.90 | $1,558 |
| 99239 Hospital Discharge Management | Facility | 23 | 21 | $95.33 | $2,193 |
| 99232 Hospital E&M - Subsequent | Facility | 19 | 11 | $68.75 | $1,306 |
| 93308 Echocardiography (TTE/TEE) | Office | 17 | 15 | $21.27 | $362 |
By year: 2022 $70K for 1,525 services; 2023 $70K for 1,211 services; 2024 $61K for 1,170 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard K Cheng prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 401 prescriptions and refills. In total Richard K Cheng wrote 3,153 Medicare prescriptions that cost $12.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 401 | 495 | 47 | $11.3M |
| Eliquis Apixaban | 149 | 338 | 39 | $198K |
| Tacrolimus Generic | 145 | 320 | 25 | $12K |
| Spironolactone Generic | 139 | 410 | 50 | $1,365 |
| Metoprolol Succinate Generic | 138 | 369 | 41 | $2,131 |
| Amlodipine Besylate Generic | 133 | 373 | 44 | $934 |
| Jardiance Empagliflozin | 133 | 342 | 41 | $183K |
| Carvedilol Generic | 132 | 361 | 48 | $1,264 |
| Losartan Potassium Generic | 127 | 373 | 41 | $1,216 |
| Atorvastatin Calcium Generic | 99 | 284 | 35 | $967 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 98 | 274 | 30 | $1,245 |
| Pravastatin Sodium Generic | 95 | 268 | 31 | $1,008 |
| Rosuvastatin Calcium Generic | 87 | 209 | 24 | $1,390 |
| Entresto Sacubitril/Valsartan | 83 | 222 | 25 | $133K |
| Potassium Chloride Generic | 73 | 173 | 26 | $2,407 |
Brand drugs: 866 claims; generic drugs: 2,257 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard K Cheng $263 ($263 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbott Laboratories with $263.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 4 | $263 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.